Skip to main content

CORRECTION article

Front. Immunol., 14 June 2024
Sec. Cancer Immunity and Immunotherapy
This article is part of the Research Topic Tertiary lymphoid structures (TLS) in the tumor immune microenvironment View all 14 articles

Corrigendum: Intratumor tertiary lymphatic structure evaluation predicts the prognosis and immunotherapy response of patients with colorectal cancer

Huijing Feng&#x;Huijing Feng1†Siyuan Zhang,,,,&#x;Siyuan Zhang2,3,4,5,6†Qiuru Zhou,,,,,Qiuru Zhou2,3,4,5,6,7Fei HanFei Han8Gang DuGang Du9Lin WangLin Wang10Xuena Yang,,,,Xuena Yang2,3,4,5,6Xiying Zhang,,,,Xiying Zhang2,3,4,5,6Wenwen Yu,,,,Wenwen Yu2,3,4,5,6Feng Wei,,,,,Feng Wei2,3,4,5,6,11Xishan Hao,,,,Xishan Hao2,3,4,5,11Xiubao Ren,,,,,,*Xiubao Ren2,3,4,5,6,11,12*Hua Zhao,,,,,*Hua Zhao2,3,4,5,6,11*
  • 1Department of Thoracic Oncology, Cancer Center, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, Shanxi, China
  • 2National Clinical Research Center for Cancer, Tianjin, China
  • 3Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
  • 4Tianjin’s Clinical Research Center for Cancer, Tianjin, China
  • 5Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China
  • 6Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
  • 7Wenzhou Central Hospital, Wenzhou, Zhejiang, China
  • 8Department of head and neck surgery, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, China
  • 9Department of Pathology, Shanxi Bethune Hospital, Taiyuan, Shanxi, China
  • 10General Surgery Department, Shanxi Bethune Hospital, Taiyuan, Shanxi, China
  • 11Haihe Laboratory of Cell Ecosystem, Tianjin, China
  • 12Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

A Corrigendum on:
Intratumor tertiary lymphatic structure evaluation predicts the prognosis and immunotherapy response of patients with colorectal cancer

By Feng H, Zhang S, Zhou Q, Han F, Du G, Wang L, Yang X, Zhang X, Yu W, Wei F, Hao X, Ren X and Zhao H (2024) Front. Immunol. 15:1302903. doi: 10.3389/fimmu.2024.1302903

In the published article, there was an error in affiliation(s) 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13. Instead of “2Tianjin Medical University Cancer Institute and Hospital, Tianjin China, 3National Clinical Research Center for Cancer, Tianjin, China, 4Key Laboratory of Cancer Prevention and Therapy, Tianjin China, 5Tianjin’s Clinical Research Center for Cancer, Tianjin China, 6Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China, 7Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China, 8Wenzhou Central Hospital, Wenzhou, Zhejiang, China, 9Department of Head and Neck Surgery, Shanxi Province Cancer Hospital/ Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, China, 10Department of Pathology, Shanxi Bethune Hospital, Taiyuan, Shanxi, China, 11General Surgery Department, Shanxi Bethune Hospital, Taiyuan, Shanxi, China, 12Haihe Laboratory of Cell Ecosystem, Tianjin, China, 13Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.”, it should be:” 2National Clinical Research Center for Cancer, Tianjin, China, 3Key Laboratory of Cancer Prevention and Therapy, Tianjin, China, 4Tianjin’s Clinical Research Center for Cancer, Tianjin, China, 5Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, China, 6Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China, 7Wenzhou Central Hospital, Wenzhou, Zhejiang, China, 8Department of head and neck surgery, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, China, 9Department of Pathology, Shanxi Bethune Hospital, Taiyuan, Shanxi, China, 10General Surgery Department, Shanxi Bethune Hospital, Taiyuan, Shanxi, China, 11Haihe Laboratory of Cell Ecosystem, Tianjin, China, 12Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

In the published article, there was an error regarding the affiliation(s) for Siyuan Zhang, Qiuru Zhou, Fei Han, Gang Du, Lin Wang, Xuena Yang, Xiying Zhang, Wenwen Yu, Feng Wei, Xishan Hao, Xiubao Ren and Hua Zhao.

Instead of Siyuan Zhang2,3,4,5,6,7†, Qiuru Zhou2,3,4,5,6,7,8, Fei Han9, Gang Du10, Lin Wang11, Xuena Yang7, Xiying Zhang7, Wenwen Yu7, Feng Wei7,12, Xishan Hao12, Xiubao Ren7,12,13* and Hua Zhao7,12*, it should be: Siyuan Zhang2,3,4,5,6†, Qiuru Zhou2,3,4,5,6,7, Fei Han8, Gang Du9, Lin Wang10, Xuena Yang2,3,4,5,6, Xiying Zhang2,3,4,5,6, Wenwen Yu2,3,4,5,6, Feng Wei2,3,4,5,6,11, Xishan Hao2,3,4,5,11, Xiubao Ren2,3,4,5,6,11,12* and Hua Zhao2,3,4,5,6,11*

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: TLS, CRC, dMMR, PMMR, anti-PD1 immunotherapy

Citation: Feng H, Zhang S, Zhou Q, Han F, Du G, Wang L, Yang X, Zhang X, Yu W, Wei F, Hao X, Ren X and Zhao H (2024) Corrigendum: Intratumor tertiary lymphatic structure evaluation predicts the prognosis and immunotherapy response of patients with colorectal cancer. Front. Immunol. 15:1397764. doi: 10.3389/fimmu.2024.1397764

Received: 08 March 2024; Accepted: 31 May 2024;
Published: 14 June 2024.

Approved by:

Frontiers in Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Feng, Zhang, Zhou, Han, Du, Wang, Yang, Zhang, Yu, Wei, Hao, Ren and Zhao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Xiubao Ren, cmVueGl1YmFvQHRqbXVjaC5jb20=; Hua Zhao, aHVhemhhb0B0bXUuZWR1LmNu

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.